Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lebriz Altay

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Investigative Ophthalmology & Visual Science|August 7, 2019
Elevated Steroid Hormone Levels in Active Chronic Central Serous ChorioretinopathyRosa L Schellevis, Lebriz Altay, Asha Kalisingh, et al.
Ophthalmology|February 6, 2018
Genome-Wide Association Study Reveals Variants in CFH and CFHR4 Associated with Systemic Complement Activation: Implications in Age-Related Macular DegenerationLaura Lorés-Motta, Constantin C Paun, Jordi Corominas, et al.
Investigative Ophthalmology & Visual Science|March 17, 2020
Complement Activation Levels Are Related to Disease Stage in AMDThomas J Heesterbeek, Yara T E Lechanteur, Laura Lorés-Motta, et al.
Translational Vision Science & Technology|June 24, 2024
Implications of Ocular Confounding Factors for Aqueous Humor Proteomic and Metabolomic Analyses in Retinal DiseasesBjörn Titz, Juliane Siebourg-Polster, Francois Bartolo, et al.
JAMA Ophthalmology|March 24, 2017
Association of a Haplotype in the NR3C2 Gene, Encoding the Mineralocorticoid Receptor, With Chronic Central Serous ChorioretinopathyElon H C van Dijk, Rosa L Schellevis, Maaike G J M van Bergen, et al.
Ophthalmology|June 9, 2022
Intravitreal 5-Fluorouracil and Heparin to Prevent Proliferative Vitreoretinopathy: Results from a Randomized Clinical TrialFriederike Schaub, Petra Schiller, Robert Hoerster, et al.
JAMA Ophthalmology|August 4, 2018
Role of the Complement System in Chronic Central Serous Chorioretinopathy: A Genome-Wide Association StudyRosa L Schellevis, Elon H C van Dijk, Myrte B Breukink, et al.
Scientific Reports|November 29, 2016
GWAS study using DNA pooling strategy identifies association of variant rs4910623 in OR52B4 gene with anti-VEGF treatment response in age-related macular degenerationMoeen Riaz, Laura Lorés-Motta, Andrea J Richardson, et al.
Medrxiv : the Preprint Server for Health Sciences|October 14, 2024
Genetic Risk of Reticular Pseudodrusen in Age-Related Macular Degeneration: <i>HTRA1</i> /lncRNA <i>BX842242.1</i> dominates, with no evidence for Complement Cascade involvementSamaneh Farashi, Carla J Abbott, Brendan Re Ansell, et al.
Nature Communications|December 8, 2025
HTRA1/lncRNA HTRA1-AS1 dominates in age-related macular degeneration reticular pseudodrusen genetic risk with no complement involvementSamaneh Farashi, Carla J Abbott, Brendan R E Ansell, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Investigative Ophthalmology & Visual Science|August 7, 2019
Elevated Steroid Hormone Levels in Active Chronic Central Serous ChorioretinopathyRosa L Schellevis, Lebriz Altay, Asha Kalisingh, et al.
Ophthalmology|February 6, 2018
Genome-Wide Association Study Reveals Variants in CFH and CFHR4 Associated with Systemic Complement Activation: Implications in Age-Related Macular DegenerationLaura Lorés-Motta, Constantin C Paun, Jordi Corominas, et al.
Investigative Ophthalmology & Visual Science|March 17, 2020
Complement Activation Levels Are Related to Disease Stage in AMDThomas J Heesterbeek, Yara T E Lechanteur, Laura Lorés-Motta, et al.
Translational Vision Science & Technology|June 24, 2024
Implications of Ocular Confounding Factors for Aqueous Humor Proteomic and Metabolomic Analyses in Retinal DiseasesBjörn Titz, Juliane Siebourg-Polster, Francois Bartolo, et al.
JAMA Ophthalmology|March 24, 2017
Association of a Haplotype in the NR3C2 Gene, Encoding the Mineralocorticoid Receptor, With Chronic Central Serous ChorioretinopathyElon H C van Dijk, Rosa L Schellevis, Maaike G J M van Bergen, et al.
Ophthalmology|June 9, 2022
Intravitreal 5-Fluorouracil and Heparin to Prevent Proliferative Vitreoretinopathy: Results from a Randomized Clinical TrialFriederike Schaub, Petra Schiller, Robert Hoerster, et al.
JAMA Ophthalmology|August 4, 2018
Role of the Complement System in Chronic Central Serous Chorioretinopathy: A Genome-Wide Association StudyRosa L Schellevis, Elon H C van Dijk, Myrte B Breukink, et al.
Scientific Reports|November 29, 2016
GWAS study using DNA pooling strategy identifies association of variant rs4910623 in OR52B4 gene with anti-VEGF treatment response in age-related macular degenerationMoeen Riaz, Laura Lorés-Motta, Andrea J Richardson, et al.
Medrxiv : the Preprint Server for Health Sciences|October 14, 2024
Genetic Risk of Reticular Pseudodrusen in Age-Related Macular Degeneration: <i>HTRA1</i> /lncRNA <i>BX842242.1</i> dominates, with no evidence for Complement Cascade involvementSamaneh Farashi, Carla J Abbott, Brendan Re Ansell, et al.
Nature Communications|December 8, 2025
HTRA1/lncRNA HTRA1-AS1 dominates in age-related macular degeneration reticular pseudodrusen genetic risk with no complement involvementSamaneh Farashi, Carla J Abbott, Brendan R E Ansell, et al.
Pageof 4